Want to see IN:NEOGEN full AI Analyst Report?
NEOGEN Stock Chart & Stats
₹2063.35
₹1.30(0.06%)
At close: 4:00 PM EDT
₹2063.35
₹1.30(0.06%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹2,785.00
Previous CloseN/A
Volume149.32K
Average Volume (3M)11.93K
Market Cap
₹65.40B
Enterprise Value₹43.23B
Total Cash (Recent Filing)₹49.50M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)164.0
Beta1.22
Next Earnings
Nov 06, 2026EPS Estimate
6.8Next Dividend Ex-DateN/A
Dividend Yield0.05%
Share Statistics
EPS (TTM)13.25
Shares Outstanding30,042,427
10 Day Avg. Volume16,365
30 Day Avg. Volume11,926
Financial Highlights & Ratios
PEG Ratio-5.85
Price to Book (P/B)3.59
Price to Sales (P/S)3.40
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.04
Revenue Forecast (FY)₹12.58B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe substantial multi-year revenue expansion indicates that Neogen has increased its commercial scale across specialty chemical markets. Continued growth can support operating leverage, broaden customer relevance, and provide a stronger base for future capacity utilization and product development.
Specialty Product PortfolioNeogen operates across bromine-based specialty intermediates and lithium-based chemicals rather than relying on a single product category. Exposure to pharmaceuticals, agrochemicals, industrial applications, and battery-related demand provides structural breadth across several downstream markets.
Qualified B2B RelationshipsSpecialty chemical customers often value consistent specifications and approved production processes, which can support repeat orders once products are qualified. This creates a potentially durable B2B relationship model and may improve retention compared with purely transactional commodity sales.
Bears Say
Higher LeverageThe sharp increase in debt has materially reduced balance-sheet flexibility while profitability and return on equity have weakened. Higher leverage can increase financing pressure, constrain capital allocation, and make future expansion more dependent on sustained operating performance.
Negative Cash GenerationNegative operating and free cash flow indicate that reported growth is not currently translating into internally generated liquidity. A large cash deficit can increase reliance on borrowing or other funding, particularly when the company is already carrying a materially higher debt load.
Margin CompressionThe latest decline in gross and net margins shows that revenue growth is producing less profit than in prior periods. Persistent pressure from pricing, product mix, or costs could weaken earnings resilience and reduce the cash available to support investment and debt service.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹2785.00 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹65.40B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 11 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on Jul 24, 2026. The company reported ₹6.25 earnings per share for the quarter, beating the consensus estimate of ₹5.14 by ₹1.11.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Overvalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.05%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate is 6.8.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 30,042,427 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹6.25 in its last earnings report, beating expectations of ₹5.14. Following the earnings report the stock price went down -1.128%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited, founded in Thane, India, in 1989, is engaged in the manufacturing and supply of an extensive array of specialized chemical products. The company's comprehensive portfolio encompasses numerous organo-bromine compounds, including alkyl bromides, dibromoalkanes, bromo chloro alkanes, various bromine derivatives (of organoacids, esters, aromatics, and cyclics), and specialty bromo-fluoro derivatives. Additionally, Neogen offers specialty chloro compounds, unsaturated and bromo-hydroxy derivatives, inorganic bromine compounds, lithium salts, Grignard reagents, and advanced intermediates. Beyond its product range, the firm also provides custom synthesis and contract manufacturing services. Neogen's offerings cater to diverse industrial sectors such as pharmaceuticals, agrochemicals, engineering, flavors and fragrances, electronic chemicals, refrigeration, construction, specialty polymers, and heating, ventilation, and air conditioning (HVAC). The company maintains an international presence, exporting its chemicals to 28 nations globally.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Balaji Amines Limited
―
Laxmi Organic Industries Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Vishnu Chemicals Limited
―